Skip to main content
Caplight Logo









Aizen Therapeutics

Aizen Therapeutics

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://www.aizentx.com/

Last Round

Seed

Nov 21, 2024

Total Funding Raised

$13M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Aizen Therapeutics is a biotechnology company that develops AI-driven mirror peptide therapeutics for the treatment of chronic immune disorders and other diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

drug discoverygenerative AIbiotechnologymirror peptidesAI drug discoveryprotein designD-amino acidsbiologicsin silico drug designtherapeutic developmentde novo designcomputational biologypeptide therapeuticsAI biotechdrug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aizen Therapeutics Comparables

Compare Aizen Therapeutics with similar companies based on industry and business-model similarity.

Aizen Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ProteinQure
81%
NuvoBio
79%
EvolutionaryScale
79%

Aizen Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 21, 2024

Key People

Founding team and executive leadership

Ajay Kshatriya

Chief Executive Officer

Executive Team

Aizen Therapeutics Investors

Notable investors and investment history

Aizen Therapeutics investors
InvestorRounds
Cercano ManagementSeed
Madrona Venture GroupSeed
Wilson Hill VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 1765% MoM.

  • Nov 21, 2024

    $13M round led by Madrona Venture Group

Recent news

Latest coverage and updates

  • has_revenueAug 17, 2026

    Aizen had revenue of $1M on Aug 15th '26.

Aizen Therapeutics Filings

Explore SEC and related filing metadata, where available.

Aizen Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Aizen Therapeutics's valuation, stock price, and market status.

Is Aizen Therapeutics a public or private company?

Aizen Therapeutics is a private company.

What is the current stock price of Aizen Therapeutics?

Aizen Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Aizen Therapeutics worth (valuation)?

Valuation information for Aizen Therapeutics is not publicly available.

Can I buy Aizen Therapeutics stock?

Aizen Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Aizen Therapeutics's last funding round?

Aizen Therapeutics's most recent funding round was Seed on November 21, 2024.

Who are the main investors in Aizen Therapeutics?

Key investors in Aizen Therapeutics include Madrona Venture Group.

Will Aizen Therapeutics IPO soon?

No public IPO plans have been announced for Aizen Therapeutics.

How can I track Aizen Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aizen Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Diego, California
Employee Range14
Year Founded2022
Last FundingNov 21, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?